Latest OPSSD News
Over the course of her Pilot Project funded by Women’s Health Research at Yale, Carolyn Fredericks, MD, assistant professor of neurology, forged interdisciplinary partnerships to propel her research forward.
- December 20, 2024
One of Women’s Health Research at Yale’s major initiatives is to mentor the next generation of health care professionals and researchers about the value of studying the influence of sex on health and disease as well as ensuring that findings are translated into clinical care.
- December 15, 2024
On Friday, September 20th, the Kavli Institute for Neuroscience at Yale celebrated 20 years of research and innovation since its inception in 2004. Over 200 Yale faculty members, postdocs, staff, and students gathered at The Anlyan Center (TAC) for a day-long symposium to share their research and insights.
- December 13, 2024
Gustavo A. Angarita, MD, MHS; Joao P. De Aquino, MD; Matthew Girgenti, PhD; Elizabeth Goldfarb, PhD; and Rajiv Radhakrishnan, MD, have been elected to Associate Membership of the American College of Neuropsychopharmacology.
- November 26, 2024
AZA Allsop, MD, PhD, assistant professor of psychiatry, has been named a National Academy of Medicine Emerging Leaders in Health and Medicine Scholar.
- November 18, 2024
Anahita Bassir Nia, MD, assistant professor of psychiatry, has been selected as a funding recipient of the American College of Neuropsychopharmacology (ACNP) Early-Stage Investigator Assistance Program.
- November 15, 2024
Yale Child Study Center Assistant Professor Emily Olfson is one of four 2024 Young Investigator Award recipients from the Tourette Association of America (TAA). Each awardee will receive $150,000 over two years to support their Tourette Syndrome and Tic Disorder research.
- November 13, 2024
Seven Yale School of Medicine faculty receive Yale Faculty Innovation Awards.
- November 13, 2024
Two Yale School of Medicine scientists have been awarded a five-year, $76 million grant from the National Institutes of Health (NIH) for their project titled, “ProCAN: Psychosis-Risk Outcomes Compound Assessment Network,” as part of the Accelerated Medicines Partnership® – Schizophrenia (AMP® SCZ). Scott W. Woods, MD, Elizabeth Mears and House Jameson Professor of Psychiatry, and Youngsun T. Cho, MD, PhD, assistant professor of psychiatry and in the Child Study Center, will lead the five-year study in collaboration with investigators from 17 other research sites.
- November 05, 2024
David Braun, MD, PhD, assistant professor of medicine (medical oncology), pathology, and urology at Yale School of Medicine and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, received the Christopher G. Wood Rising Star Award by the Kidney Cancer Association at the 2024 International Kidney Cancer Symposium in Louisville, KY.